Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a groundbreaking remedy for obesity and type 2 diabetes. It mimics the effects of GLP-1, a naturally occurring hormone that regulates appetite, blood sugar, and insulin secretion. When...

read more